{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:23:21Z","timestamp":1792531401357,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The emergence of <jats:italic>Plasmodium falciparum<\/jats:italic> resistant to frontline therapeutics has prompted efforts to identify and validate agents with novel mechanisms of action. MEPicides represent a new class of antimalarials that inhibit enzymes of the methylerythritol phosphate (MEP) pathway of isoprenoid biosynthesis, including the clinically validated target, deoxyxylulose phosphate reductoisomerase (Dxr). Here we describe RCB-185, a lipophilic prodrug with nanomolar activity against asexual parasites. Growth of <jats:italic>P. falciparum<\/jats:italic> treated with RCB-185 was rescued by isoprenoid precursor supplementation, and treatment substantially reduced metabolite levels downstream of the Dxr enzyme. In addition, parasites that produced higher levels of the Dxr substrate were resistant to RCB-185. Notably, environmental isolates resistant to current therapies remained sensitive to RCB-185, the compound effectively treated sexually-committed parasites, and was both safe and efficacious in malaria-infected mice. Collectively, our data demonstrate that RCB-185 potently and selectively inhibits Dxr in <jats:italic>P. falciparum<\/jats:italic>, and represents a promising lead compound for further drug development.<\/jats:p>","DOI":"10.1038\/s41598-017-07159-y","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T11:35:42Z","timestamp":1502364942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-7440","authenticated-orcid":false,"given":"Rachel L.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Brothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim I.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Ziniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Hruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim C.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-8537","authenticated-orcid":false,"given":"Audrey R. Odom","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"7159_CR1","unstructured":"World Health Organization. World Malaria Report (2016)."},{"key":"7159_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. \n                           361, 455\u201367 (2009).","journal-title":"N. Engl. J. Med."},{"key":"7159_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. \n                           371, 411\u201323 (2014).","journal-title":"N. Engl. J. Med."},{"key":"7159_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMc1612765","volume":"376","author":"F Lu","year":"2017","unstructured":"Lu, F. et al. Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa. N. Engl. J. Med. \n                           376, 991\u2013993 (2017).","journal-title":"N. Engl. J. Med."},{"key":"7159_CR5","doi-asserted-by":"publisher","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","volume":"9","author":"E Yeh","year":"2011","unstructured":"Yeh, E. & DeRisi, J. L. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. \n                           9, e1001138 (2011).","journal-title":"PLoS Biol."},{"key":"7159_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrmicro843","volume":"2","author":"SA Ralph","year":"2004","unstructured":"Ralph, S. A. et al. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. \n                           2, 203\u201316 (2004).","journal-title":"Nat. Rev. Microbiol."},{"key":"7159_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40588-014-0006-7","volume":"1","author":"L Imlay","year":"2014","unstructured":"Imlay, L. & Odom, A. R. Isoprenoid metabolism in apicomplexan parasites. Curr. Clin. Microbiol. reports \n                           1, 37\u201350 (2014).","journal-title":"Curr. Clin. Microbiol. reports"},{"key":"7159_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molbiopara.2009.12.001","volume":"170","author":"AR Odom","year":"2010","unstructured":"Odom, A. R. & Van Voorhis, W. C. Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene. Mol. Biochem. Parasitol. \n                           170, 108\u201311 (2010).","journal-title":"Mol. Biochem. Parasitol."},{"key":"7159_CR9","doi-asserted-by":"publisher","first-page":"9740","DOI":"10.1021\/jm5010978","volume":"57","author":"T Masini","year":"2014","unstructured":"Masini, T. & Hirsch, A. K. H. Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents. J. Med. Chem. \n                           57, 9740\u201363 (2014).","journal-title":"J. Med. Chem."},{"key":"7159_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/156802612799984599","volume":"12","author":"ER Jackson","year":"2012","unstructured":"Jackson, E. R. & Dowd, C. S. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors. Curr. Top. Med. Chem. \n                           12, 706\u201328 (2012).","journal-title":"Curr. Top. Med. Chem."},{"key":"7159_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2174\/138161207780618939","volume":"13","author":"N Singh","year":"2007","unstructured":"Singh, N., Cheve, G., Avery, M. & McCurdy, C. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Curr. Pharm. Des. \n                           13, 1161\u20131177 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"7159_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.drudis.2013.07.003","volume":"18","author":"T Masini","year":"2013","unstructured":"Masini, T., Kroezen, B. S. & Hirsch, A. K. H. Druggability of the enzymes of the non-mevalonate-pathway. Drug Discov. Today \n                           18, 1256\u201362 (2013).","journal-title":"Drug Discov. Today"},{"key":"7159_CR13","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1021\/bi200113y","volume":"50","author":"B Zhang","year":"2011","unstructured":"Zhang, B. et al. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. Biochemistry \n                           50, 3570\u20133577 (2011).","journal-title":"Biochemistry"},{"key":"7159_CR14","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.febslet.2013.06.024","volume":"587","author":"VK Singh","year":"2013","unstructured":"Singh, V. K. & Ghosh, I. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum. FEBS Lett. \n                           587, 2806\u201317 (2013).","journal-title":"FEBS Lett."},{"key":"7159_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TNC Wells","year":"2015","unstructured":"Wells, T. N. C., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nat. Rev. Drug Discov. \n                           14, 424\u201342 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7159_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/bi0118207","volume":"41","author":"AT Koppisch","year":"2002","unstructured":"Koppisch, A. T., Fox, D. T., Blagg, B. S. J. & Poulter, C. D. E. coli MEP synthase: steady-state kinetic analysis and substrate binding. Biochemistry \n                           41, 236\u2013243 (2002).","journal-title":"Biochemistry"},{"key":"7159_CR17","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1016\/S0040-4039(98)01755-9","volume":"39","author":"T Kuzuyama","year":"1998","unstructured":"Kuzuyama, T., Shimizu, T., Takahashi, S. & Seto, H. Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis. Tetrahedron Lett. \n                           39, 7913\u20137916 (1998).","journal-title":"Tetrahedron Lett."},{"key":"7159_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7164\/antibiotics.33.29","volume":"33","author":"Y Kuroda","year":"1980","unstructured":"Kuroda, Y. et al. Studies on new phosphonic acid antibiotics. IV. Structure determination of FR-33289, FR-31564 and FR-32863. J. Antibiot. (Tokyo). \n                           33, 29\u201335 (1980).","journal-title":"J. Antibiot. (Tokyo)."},{"key":"7159_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.7164\/antibiotics.33.24","volume":"33","author":"M Okuhara","year":"1980","unstructured":"Okuhara, M. et al. Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J. Antibiot. (Tokyo). \n                           33, 24\u20138 (1980).","journal-title":"J. Antibiot. (Tokyo)."},{"key":"7159_CR20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","volume":"285","author":"H Jomaa","year":"1999","unstructured":"Jomaa, H. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science. \n                           285, 1573\u20131576 (1999).","journal-title":"Science."},{"key":"7159_CR21","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1021\/jm5019719","volume":"58","author":"K Br\u00fccher","year":"2015","unstructured":"Br\u00fccher, K. et al. Prodrugs of reverse fosmidomycin analogues. J. Med. Chem. \n                           58, 2025\u201335 (2015).","journal-title":"J. Med. Chem."},{"key":"7159_CR22","unstructured":"Kamiya, T., Hashimoto, M., Hemmi, K. & Tekeno, H. Hydroxyaminohydrocarbonphosphonic acids 1\u201374 (1978)."},{"key":"7159_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1128\/AAC.21.2.224","volume":"21","author":"T Murakawa","year":"1982","unstructured":"Murakawa, T., Sakamoto, H., Fukada, S., Konishi, T. & Nishida, M. Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic. Antimicrob. Agents Chemother. \n                           21, 224\u201330 (1982).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7159_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/AAC.47.2.735-738.2003","volume":"47","author":"B Lell","year":"2003","unstructured":"Lell, B. et al. Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob. Agents Chemother. \n                           47, 735\u20138 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7159_CR25","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","volume":"360","author":"MA Missinou","year":"2002","unstructured":"Missinou, M. A. et al. Fosmidomycin for malaria. Lancet (London, England) \n                           360, 1941\u20132 (2002).","journal-title":"Lancet (London, England)"},{"key":"7159_CR26","first-page":"515","volume":"23","author":"HP Kuemmerle","year":"1985","unstructured":"Kuemmerle, H. P., Murakawa, T., Soneoka, K. & Konishi, T. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies. Int. J. Clin. Pharmacol. Ther. Toxicol. \n                           23, 515\u201320 (1985).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"7159_CR27","first-page":"521","volume":"23","author":"HP Kuemmerle","year":"1985","unstructured":"Kuemmerle, H. P. et al. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies. Int. J. Clin. Pharmacol. Ther. Toxicol. \n                           23, 521\u20138 (1985).","journal-title":"Preliminary early phase IIa clinical studies. Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"7159_CR28","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1128\/AAC.00018-12","volume":"56","author":"M Lanaspa","year":"2012","unstructured":"Lanaspa, M. et al. Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria. Antimicrob. Agents Chemother. \n                           56, 2923\u20138 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7159_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/1475-2875-11-316","volume":"11","author":"MP Anthony","year":"2012","unstructured":"Anthony, M. P., Burrows, J. N., Duparc, S., Moehrle, J. J. & Wells, T. N. C. The global pipeline of new medicines for the control and elimination of malaria. Malar. J. \n                           11, 316 (2012).","journal-title":"Malar. J."},{"key":"7159_CR30","doi-asserted-by":"publisher","first-page":"A22.3","DOI":"10.1136\/bmjgh-2016-000260.57","volume":"2","author":"G Mombo-Ngoma","year":"2017","unstructured":"Mombo-Ngoma, G. et al. Fosmidomycin-piperaquine as non-artemisinin-based combination for acute uncomplicated Plasmodium falciparum malaria. BMJ Glob. Heal. \n                           2, A22.3\u2013A23 (2017).","journal-title":"BMJ Glob. Heal."},{"key":"7159_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bmcl.2013.11.067","volume":"24","author":"ER Jackson","year":"2014","unstructured":"Jackson, E. R. et al. The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs. Bioorg. Med. Chem. Lett. \n                           24, 649\u201353 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7159_CR32","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1016\/j.bmcl.2011.09.123","volume":"21","author":"E Uh","year":"2011","unstructured":"Uh, E. et al. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs. Bioorg. Med. Chem. Lett. \n                           21, 6973\u20136 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7159_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1039\/c2md20079a","volume":"3","author":"TS Elliott","year":"2012","unstructured":"Elliott, T. S. et al. The use of phosphate bioisosteres in medicinal chemistry and chemical biology. Medchemcomm \n                           3, 735 (2012).","journal-title":"Medchemcomm"},{"key":"7159_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0968-0896(02)00552-7","volume":"11","author":"C Schultz","year":"2003","unstructured":"Schultz, C. Prodrugs of biologically active phosphate esters. Bioorg. Med. Chem. \n                           11, 885\u2013898 (2003).","journal-title":"Bioorg. Med. Chem."},{"key":"7159_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2004.70.119","volume":"70","author":"Y Corbett","year":"2004","unstructured":"Corbett, Y. et al. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am. J. Trop. Med. Hyg. \n                           70, 119\u2013124 (2004).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"7159_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/srep00009","volume":"1","author":"T Umeda","year":"2011","unstructured":"Umeda, T. et al. Molecular basis of fosmidomycin\u2019s action on the human malaria parasite Plasmodium falciparum. Sci. Rep. \n                           1, 9 (2011).","journal-title":"Sci. Rep."},{"key":"7159_CR37","doi-asserted-by":"publisher","first-page":"19905","DOI":"10.1074\/jbc.M701935200","volume":"282","author":"LM Henriksson","year":"2007","unstructured":"Henriksson, L. M. et al. Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis. J. Biol. Chem. \n                           282, 19905\u201316 (2007).","journal-title":"J. Biol. Chem."},{"key":"7159_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1021\/id500047s","volume":"1","author":"LS Imlay","year":"2015","unstructured":"Imlay, L. S. et al. Plasmodium IspD (2-C-methyl-D-erythritol 4-phosphate cytidyltransferase), an essential and druggable antimalarial target. ACS Infect. Dis. \n                           1, 157\u2013167 (2015).","journal-title":"ACS Infect. Dis."},{"key":"7159_CR39","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1038\/ncomms5467","volume":"5","author":"AM Guggisberg","year":"2014","unstructured":"Guggisberg, A. M. et al. A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites. Nat. Commun. \n                           5, 4467 (2014).","journal-title":"Nat. Commun."},{"key":"7159_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QCO.0000000000000199","volume":"28","author":"RM Fairhurst","year":"2015","unstructured":"Fairhurst, R. M. Understanding artemisinin-resistant malaria: what a difference a year makes. Curr. Opin. Infect. Dis. \n                           28, 417\u201325 (2015).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"7159_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde, W. A. et al. Chemical genetics of Plasmodium falciparum. Nature \n                           465, 311\u20135 (2010).","journal-title":"Nature"},{"key":"7159_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm.3073","volume":"19","author":"LH Miller","year":"2013","unstructured":"Miller, L. H., Ackerman, H. C., Su, X. & Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. \n                           19, 156\u201367 (2013).","journal-title":"Nat. Med."},{"key":"7159_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1128\/EC.00198-14","volume":"14","author":"JD Wiley","year":"2015","unstructured":"Wiley, J. D. et al. Isoprenoid precursor biosynthesis is the essential metabolic role of the apicoplast during gametocytogenesis in Plasmodium falciparum. Eukaryot. Cell \n                           14, 128\u2013139 (2015).","journal-title":"Eukaryot. Cell"},{"key":"7159_CR44","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/AAC.01500-13","volume":"58","author":"JD Bowman","year":"2014","unstructured":"Bowman, J. D. et al. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. Antimicrob. Agents Chemother. \n                           58, 811\u20139 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7159_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/1475-2875-12-408","volume":"12","author":"S Duffy","year":"2013","unstructured":"Duffy, S. & Avery, V. M. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar. J. \n                           12, 408 (2013).","journal-title":"Malar. J."},{"key":"7159_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2875-11-34","volume":"11","author":"CL Peatey","year":"2012","unstructured":"Peatey, C. L., Leroy, D., Gardiner, D. L. & Trenholme, K. R. Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? Malar. J. \n                           11, 34 (2012).","journal-title":"Malar. J."},{"key":"7159_CR47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","volume":"97","author":"LD Marroquin","year":"2007","unstructured":"Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D. & Will, Y. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol. Sci. \n                           97, 539\u201347 (2007).","journal-title":"Toxicol. Sci."},{"key":"7159_CR48","doi-asserted-by":"publisher","unstructured":"Verlinden, B. K., Louw, A. & Birkholtz, L.-M. Resisting resistance: is there a solution for malaria? Expert Opin. Drug Discov. 1\u201312, doi:10.1517\/17460441.2016.1154037 (2016).","DOI":"10.1517\/17460441.2016.1154037"},{"key":"7159_CR49","doi-asserted-by":"publisher","first-page":"51749","DOI":"10.1074\/jbc.M408360200","volume":"279","author":"MB Cassera","year":"2004","unstructured":"Cassera, M. B. et al. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum. J. Biol. Chem. \n                           279, 51749\u201359 (2004).","journal-title":"J. Biol. Chem."},{"key":"7159_CR50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/1475-2875-12-408","volume":"12","author":"S Duffy","year":"2013","unstructured":"Duffy, S. & Avery, V. M. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar. J. \n                           12, 408 (2013).","journal-title":"Malar. J."},{"key":"7159_CR51","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/0020-7519(90)90056-S","volume":"20","author":"A Saul","year":"1990","unstructured":"Saul, A., Graves, P. & Edser, L. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol. Int. J. Parasitol. \n                           20, 1095\u20137 (1990).","journal-title":"Int. J. Parasitol."},{"key":"7159_CR52","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.1021\/jm4006498","volume":"56","author":"AM Jansson","year":"2013","unstructured":"Jansson, A. M. et al. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues. J. Med. Chem. \n                           56, 6190\u20139 (2013).","journal-title":"J. Med. Chem."},{"key":"7159_CR53","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0960-894X(01)00075-0","volume":"11","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg, A. et al. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg. Med. Chem. Lett. \n                           11, 833\u2013835 (2001).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7159_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ardp.200500976","volume":"338","author":"R Ortmann","year":"2005","unstructured":"Ortmann, R. et al. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Arch. Pharm. (Weinheim). \n                           338, 305\u201314 (2005).","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"7159_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ardp.200700069","volume":"340","author":"J Wiesner","year":"2007","unstructured":"Wiesner, J., Ortmann, R., Jomaa, H. & Schlitzer, M. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity. Arch. Pharm. (Weinheim). \n                           340, 667\u20139 (2007).","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"7159_CR56","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.bmcl.2005.12.082","volume":"16","author":"T Haemers","year":"2006","unstructured":"Haemers, T. et al. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors. Bioorg. Med. Chem. Lett. \n                           16, 1888\u201391 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7159_CR57","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1021\/jm100211e","volume":"53","author":"T Verbrugghen","year":"2010","unstructured":"Verbrugghen, T., Cos, P., Maes, L. & Van Calenbergh, S. Synthesis and evaluation of alpha-halogenated analogues of 3-(acetylhydroxyamino)propylphosphonic acid (FR900098) as antimalarials. J. Med. Chem. \n                           53, 5342\u20136 (2010).","journal-title":"J. Med. Chem."},{"key":"7159_CR58","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1021\/jm200694q","volume":"54","author":"CT Behrendt","year":"2011","unstructured":"Behrendt, C. T. et al. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr). J. Med. Chem. \n                           54, 6796\u2013802 (2011).","journal-title":"J. Med. Chem."},{"key":"7159_CR59","first-page":"390","volume":"52","author":"NNNA Rahman","year":"1997","unstructured":"Rahman, N. N. N. A. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi malaria to various drugs and their combinations. Med. J. Malaysia \n                           52, 390\u2013398 (1997).","journal-title":"Med. J. Malaysia"},{"key":"7159_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0035-9203(84)90114-7","volume":"78","author":"TR Burkot","year":"1984","unstructured":"Burkot, T. R., Williams, J. L. & Schneider, I. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans. R. Soc. Trop. Med. Hyg. \n                           78, 339\u201341 (1984).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"7159_CR61","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. Human malaria parasites in continuous culture. Science. \n                           193, 673\u2013675 (1976).","journal-title":"Science."},{"key":"7159_CR62","first-page":"1977","volume":"13","author":"K Okano","year":"2008","unstructured":"Okano, K., Okuyama, K.-I., Fukuyama, T. & Tokuyama, H. Mild debenzylation of aryl benzyl ether with BCl3 in the presence of pentamethylbenzene as a non-Lewis-basic cation scavenger. Synlett \n                           13, 1977\u20131980 (2008).","journal-title":"Synlett"},{"key":"7159_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chroma.2007.02.034","volume":"1147","author":"B Luo","year":"2007","unstructured":"Luo, B., Groenke, K., Takors, R., Wandrey, C. & Oldiges, M. Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry. J. Chromatogr. A \n                           1147, 153\u2013164 (2007).","journal-title":"J. Chromatogr. A"},{"key":"7159_CR64","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1128\/AAC.01930-13","volume":"59","author":"TQ Tanaka","year":"2015","unstructured":"Tanaka, T. Q. et al. Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen. Antimicrob. Agents Chemother. \n                           59, 1389\u201397 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7159_CR65","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/srep00118","volume":"1","author":"B Malleret","year":"2011","unstructured":"Malleret, B. et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci. Rep. \n                           1, 118 (2011).","journal-title":"Sci. Rep."},{"key":"7159_CR66","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1073\/pnas.0503386102","volume":"102","author":"B Franke-Fayard","year":"2005","unstructured":"Franke-Fayard, B. et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA \n                           102, 11468\u201311473 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07159-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:08:48Z","timestamp":1671786528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07159-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"18 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8400"}}